Cagrilintide Semaglutide
Cagrilintide is a long-acting analogue of amylin. It is being tested to treat obesity and type 2 diabetes by itself and in combination with semaglutide Semaglutide is an anti-diabetic medication used for the treatment of type2 diabetes and an anti-obesity medication used for long-term weight management. It is a peptide similar to the hormone glucagon-like peptide-1 (GLP-1), modified with a ... as cagrilintide/semaglutide. Research A systematic review and metanalysis of cagrisema, published in 2024, found that cagrisema may provide weight loss benefits. References Amylin receptor agonists Experimental diabetes drugs Cyclic peptides Peptide therapeutics {{gastrointestinal-drug-stub ...
[...More Info...]       [...Related Items...]     OR:     [Wikipedia]   [Google]   [Baidu]